Platinum resistance related to a functional NER pathway

被引：38

作者：

Rosell, Rafael ^{[1
]}

Mendez, Pedro ^{[1
]}

Isla, Dolores ^{[2
]}

Taron, Miquel ^{[1
]}

机构：

[1] Catalan Inst Oncol, Badalona, Spain

[2] Hosp Clin Zaragoza, Zaragoza, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2007年 / 2卷 / 12期

关键词：

D O I：

10.1097/JTO.0b013e31815ba2a1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：1063 / 1066

页数：4

相关论文

共 29 条

[1] BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair [J].

Abbott, DW ;

Thompson, ME ;

Robinson-Benion, C ;

Tomlinson, G ;

Jensen, RA ;

Holt, JT .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18808-18812

[2] Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer:: A Spanish lung cancer group phase III randomized trial [J].

Alberola, V ;

Camps, C ;

Provencio, M ;

Isla, D ;

Rosell, R ;

Vadell, C ;

Bover, I ;

Ruiz-Casado, A ;

Azagra, P ;

Jiménez, U ;

González-Larriba, JL ;

Diz, P ;

Cardenal, F ;

Artal, A ;

Carrato, A ;

Morales, S ;

Sánchez, JJ ;

de las Peñas, R ;

Felip, E ;

López-Vivanco, G .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3207-3213

[3] DNA damage-processing pathways involved in the eukaryotic cellular response to anticancer DNA cross-linking drugs [J].

Beljanski, V ;

Marzilli, LG ;

Doetsch, PW .

MOLECULAR PHARMACOLOGY, 2004, 65 (06) :1496-1506

[4] Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression:: A phase III trial in non-small-cell lung cancer [J].

Cobo, Manuel ;

Isla, Dolores ;

Massuti, Bartomeu ;

Montes, Ana ;

Miguel Sanchez, Jose ;

Provencio, Mariano ;

Vinolas, Nuria ;

Paz-Ares, Luis ;

Lopez-Vivanco, Guillermo ;

Angel Munoz, Miguel ;

Felip, Enriqueta ;

Alberola, Vicente ;

Camps, Carlos ;

Domine, Manuel ;

Sanchez, Jose Javier ;

Sanchez-Ronco, Maria ;

Danenberg, Kathleen ;

Taron, Miquel ;

Gandara, David ;

Rosell, Rafael .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) :2747-2754

[5] XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells:: Role of ERCC1 in homologous recombination repair [J].

Cummings, Michele ;

Higginbottom, Karen ;

McGurk, Claire J. ;

Wong, Oscar Gee-Wang ;

Koberle, Beate ;

Oliver, R. Timothy D. ;

Masters, John R. .

BIOCHEMICAL PHARMACOLOGY, 2006, 72 (02) :166-175

[6] MESSENGER-RNA LEVELS OF XPAC AND ERCC1 IN OVARIAN-CANCER TISSUE CORRELATE WITH RESPONSE TO PLATINUM-BASED CHEMOTHERAPY [J].

DABHOLKAR, M ;

VIONNET, J ;

BOSTICKBRUTON, F ;

YU, JJ ;

REED, E .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) :703-708

[7] Molecular mechanism of nucleotide excision repair [J].

de Laat, WL ;

Jaspers, NGJ ;

Hoeijmakers, JHJ .

GENES & DEVELOPMENT, 1999, 13 (07) :768-785

[8]

Furuta T, 2002, CANCER RES, V62, P4899

[9] Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells:: role of myeloperoxidase [J].

Gungor, Nejla ;

Godschalk, Roger W. L. ;

Pachen, Danielle M. ;

Van Schooten, Frederik J. ;

Knaapen, Ad M. .

FASEB JOURNAL, 2007, 21 (10) :2359-2367

[10]

Husain A, 1998, CANCER RES, V58, P1120